CASH FLOW DISCLOSURES AND NON CASH INVESTING AND FINANCING ACTIVITIES (Tables)

9 Months Ended

Sep. 30, 2021

Supplemental Cash Flow Elements [Abstract]

Schedule of cash flow

The following non-cash investing and financing activities occurred during the nine months ended September 30, 2021 and 2020:

	2021		2020
Common Shares issued as part of the Dividend Reinvestment Plan	$	—	$	14
Issuance of share based payments	13,967		7,259
Accrued payables for capital expenditures placed into service	148		892
Increase in accrued liabilities related to insurance premium financing agreement	5,173		—
Adjustment to Record Noncontrolling Interest at Redemption Value	1,968		(3,196)

Schedule of cash and cash equivalents

The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts shown in the consolidated statements of cash flows for the nine months ended September 30, 2021 and 2020:

	2021		2020
Cash and cash equivalents	$	71,244	$	13,139
Escrowed cash	12,497		7,124
Total cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows	$	83,741	$	20,263

Summary of restrictions on cash and cash equivalents

The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts shown in the consolidated statements of cash flows for the nine months ended September 30, 2021 and 2020:

	2021		2020
Cash and cash equivalents	$	71,244	$	13,139
Escrowed cash	12,497		7,124
Total cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows	$	83,741	$	20,263